IN THIS ISSUE:
PUBLIC HEALTH ADVISORY
Reports of Valvular Heart Disease in Patients Receiving Concomitant Fenfluramine and Phentermine
Future Meetings
Protease Inhibitors May Increase Blood Glucose in HIV Patients
New Treatment for Orphan Disease, Essential Thrombocythemia
Natural Rubber Latex Allergy
Reminder for Physicians Interpreting Mammograms
Medication Errors
Confusion with Brevibloc Injection Dosage Forms
FDA Warns Against Dietary Supplement Product, "Chomper"
From the medWatch Office
Summaries of "Dear Health Professional" Letters and Other Safety Notifications FDA Requests Help in Evaluating Therapeutic Switches
medWatch Continuing Education Article
Safety-Related Drug Labeling Changes Approved by FDA
Obtaining a medWatch Reporting Form
Editorial Board
Change of Address
FDA Telephone Numbers
REPORT SERIOUS ADVERSE EVENTS AND PRODUCT PROBLEMS
1-800-FDA-1088
FDA Home Page
|
Search
|
A-Z Index
|
Site Map
|
Contact FDA
FDA/Website Management Staff